Dashboard
Manage Tickers

UCBJFU C B


$ 0.55 (0.31 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 179.05
-- x --
-- x --
-- - --
$ 68.91 - $ 180.00
140
na
nm
$ 0.82
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

longboard-pharmaceuticals-boasts-high-value-epilepsy-assets-analyst-initiates-coverage
Longboard Pharmaceuticals Boasts High-Valu...
09/10/2024 18:13:01

Truist Securities initiated coverage on Longboard Pharmaceuticals, citing it as a CNS-focused biotech with high-value epilepsy ...

johnson--johnson-seeks-fda-approval-for-muscle-weakness-drug-and-gears-up-showdown-with-argenx-and-ucb
Johnson & Johnson Seeks FDA Approval For M...
08/29/2024 16:29:10

Johnson & Johnson has submitted a Biologics License Application (BLA) to the FDA for nipocalimab, seeking its first global ...

belgium-based-pharma-firm-ucb-to-offload-china-neurology-allergy-business-for-680m-to-asset-management-companies
Belgium-Based Pharma Firm UCB To Offload C...
08/26/2024 11:51:04

UCB announces a $680 million strategic divestment deal in China, selling its neurology and allergy business to CBC Group and Mu...

theres-optimism-around-longboard-pharmaceuticals-anti-seizure-candidate-analyst-boosts-price-target
There's Optimism Around Longboard Pharmace...
01/02/2024 18:55:05

Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexic...

dianthus-monoclonal-antibody-on-promising-pathway-to-gaining-the-upper-hand---analyst
Dianthus' Monoclonal Antibody On Promising...
09/28/2023 19:33:57

Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Ther...

skin-disease-focused-moonlake-immunotherapeutics-poised-to-outshine-rivals-analyst-asserts
Skin Disease Focused MoonLake Immunotherap...
08/31/2023 17:38:19

Needham initiated coverage on MoonLake Immunotherapeutics (NASDAQ: MLTX) with a Buy rating and 

fda-approves-rystiggo-the-only-treatment-for-two-most-common-subtypes-of-generalized-myasthenia-gravis-in-adults
FDA Approves Rystiggo: The Only Treatment ...
06/27/2023 17:47:04

The FDA approved UCB SA's (OTC: UCBJF) (OTC: UCBJY) Rystiggo (rozanolixizumab-noli) for generalized myasthenia gravis (gMG)...

cantor-on-moonlake-immunotherapeutics---initiates-on-inexpensive-valuation-strong-catalyst-path
Cantor On MoonLake Immunotherapeutics - In...
02/14/2023 18:02:14

ucbs-rare-childhood-epilepsy-drug-scores-fda-approval
UCB's Rare Childhood Epilepsy Drug Scores ...
03/28/2022 16:00:58

biogen-xbrane-enter-license-agreement-for-cimzia-referenced-biosimilar-xcimzane
Biogen-Xbrane Enter License Agreement For ...
02/08/2022 14:57:17

Biogen Inc (NASDAQ: BIIB) and Xbrane Biopharma AB have 

ucbs-bispecific-marks-phase-3-win-for-second-psoriatic-arthritis-study
UCB's Bispecific Marks Phase 3 Win For Sec...
01/21/2022 17:10:34

UCB SA (OTC: UCBJF) 

ucb-to-buy-epilepsy-focused-zogenix-in-19b-deal-see-the-highlights
UCB to Buy Epilepsy-Focused Zogenix In $1....
01/19/2022 11:08:38

Belgian-based UCB SA (OTC: UCBJF) has agreed to buy Zogenix Inc (NASDAQ: ZGNX), a U.S.

ucb-gets-eu-approval-for-bimekizumab-in-psoriasis
UCB Gets EU Approval For Bimekizumab In Ps...
08/25/2021 19:18:32

ra-pharma-stock-doubles-on-25b-buyout-deal-with-belgian-biopharma-ucb
Ra Pharma Stock Doubles On $2.5B Buyout De...
10/10/2019 16:31:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION